The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease
Open accessAbstract
Although α-synuclein (α-SYN) aggregation is a hallmark of sporadic and familial Parkinson's disease (PD), it is not known how it contributes to early events of PD pathogenesis such as oxidative and inflammatory stress. Here, we addressed this question in a new animal model based on stereotaxic delivery of an adeno-associated viral vector (rAAV) for expression of human α-SYN in the ventral midbrain of mice lacking the transcription factor Nrf2 (Nrf2(-/-)). Two months after surgery, Nrf2(-/-) mice exhibited exacerbated degeneration of nigral dopaminergic neurons and increased dystrophic dendrites, reminiscent of Lewy neurites, which correlated with impaired proteasome gene expression and activity. Dopaminergic neuron loss was associated with an increase in neuroinflammation and gliosis that were intensified in Nrf2(-/-) mice. In response to exogenously added α-SYN, Nrf2(-/-) microglia failed to activate the expression of two anti-inflammatory genes, heme oxygenase-1 (HO-1) and nicotinamide adenine dinucleotide phosphate quinone oxidorreductase-1 (NQO1). This impaired Nrf2 response correlated with a shift in the microglial activation profile, towards increased production of proinflammatory markers, IL-6, IL-1β and iNOS and reduced phagocytic capacity of fluorescent beads, and lower messenger RNA levels for TAM receptors Axl and Mer. Postmortem brain tissue samples from patients in early- to middle-stage progression of PD showed increased HO-1 expression in astrocytes and microglia, suggesting an attempt of the diseased brain to compensate these hallmarks of PD through activation of the Nrf2 pathway. This study demonstrates that α-SYN and Nrf2 deficiency cooperate on protein aggregation, neuroinflammation and neuronal death and provides a bifactorial animal model to study early-stage PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 13,417
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
The mouse brain in stereotaxic coordinates
Konsman, J.-P. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00088-x · Cited by 4,045
Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
The efficiency of systematic sampling in stereology and its prediction*
Gundersen, H. J. G., & Jensen, E. B. (1987) · Journal of Microscopy · doi:10.1111/j.1365-2818.1987.tb02837.x · Cited by 3,520
West, M. J., Slomianka, L., & Gundersen, H. J. G. (1991) · The Anatomical Record · doi:10.1002/ar.1092310411 · Cited by 2,994
Lees, A. J., Hardy, J., & Revesz, T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60492-x · Cited by 1,956
Zhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.-S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2751com · Cited by 1,265
Lee, H.-J., Suk, J.-E., Patrick, C., Bae, E.-J., Cho, J.-H., Rho, S., Hwang, D., Masliah, E., & Lee, S.-J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.081125 · Cited by 877
Stress-activated cap’n’collar transcription factors in aging and human disease
Sykiotis, G. P., & Bohmann, D. (2010) · Science Signaling · doi:10.1126/scisignal.3112re3 · Cited by 776
Suh, J. H., Shenvi, S. V., Dixon, B. M., Liu, H., Jaiswal, A. K., Liu, R.-M., & Hagen, T. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400282101 · Cited by 772
Expression of Nrf2 in Neurodegenerative Diseases
Ramsey, C. P., Glass, C. A., Montgomery, M. B., Lindl, K. A., Ritson, G. P., Chia, L. A., Hamilton, R. L., Chu, C. T., & Jordan-Sciutto, K. L. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31802d6da9 · Cited by 760
Pathoanatomy of Parkinson’s disease
Braak, H., & Braak, E. (2000) · Journal of Neurology · doi:10.1007/pl00007758 · Cited by 693
Kirik, D., Rosenblad, C., Burger, C., Lundberg, C., Johansen, T. E., Muzyczka, N., Mandel, R. J., & Björklund, A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02780.2002 · Cited by 649
Self-citationAltered proteasomal function in sporadic Parkinson’s disease
St. P. McNaught, K., Belizaire, R., Isacson, O., Jenner, P., & Olanow, C. W. (2003) · Experimental Neurology · doi:10.1006/exnr.2002.8050 · Cited by 573
The Transcription Factor Nrf2 Is a Therapeutic Target against Brain Inflammation
Innamorato, N. G., Rojo, A. I., García-Yagüe, À. J., Yamamoto, M., de Ceballos, M. L., & Cuadrado, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.680 · Cited by 480
Self-citationBraak, H., Sastre, M., & Del Tredici, K. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0244-3 · Cited by 462
Glia: Initiators and progressors of pathology in Parkinson's disease
Halliday, G. M., & Stevens, C. H. (2011) · Movement Disorders · doi:10.1002/mds.23455 · Cited by 424
Galvin, J. E., Uryu, K., Lee, V. M.-Y., & Trojanowski, J. Q. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13450 · Cited by 422
Kirik, D., Annett, L. E., Burger, C., Muzyczka, N., Mandel, R. J., & Björklund, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0536383100 · Cited by 403
Self-citationNrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease
Rojo, A. I., Innamorato, N. G., Martín‐Moreno, A. M., De Ceballos, M. L., Yamamoto, M., & Cuadrado, A. (2010) · Glia · doi:10.1002/glia.20947 · Cited by 375
Self-citationJazwa, A., Rojo, A. I., Innamorato, N. G., Hesse, M., Fernández-Ruiz, J., & Cuadrado, A. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3731 · Cited by 327
Self-citationNeural Heme Oxygenase-1 Expression in Idiopathic Parkinson's Disease
Schipper, H. M., Liberman, A., & Stopa, E. G. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6752 · Cited by 300
Pickering, A. M., Linder, R. A., Zhang, H., Forman, H. J., & Davies, K. J. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277145 · Cited by 282
Genetic Analysis of Pathways to Parkinson Disease
Hardy, J. (2010) · Neuron · doi:10.1016/j.neuron.2010.10.014 · Cited by 274
Lotharius, J. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.20.2395 · Cited by 269
Sanchez-Guajardo, V., Febbraro, F., Kirik, D., & Romero-Ramos, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008784 · Cited by 256
Self-citationHU, R., XU, C., SHEN, G., JAIN, M., KHOR, T., GOPALKRISHNAN, A., LIN, W., REDDY, B., CHAN, J., & KONG, A. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.11.050 · Cited by 241
Animal models of Parkinson’s disease progression
Meredith, G. E., Sonsalla, P. K., & Chesselet, M.-F. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0350-x · Cited by 228
Brain Aging: Models, Methods, and Mechanisms
(2007) · CRC Press eBooks · doi:10.1201/9781420005523 · Cited by 219
St Martin, J. L., Klucken, J., Outeiro, T. F., Nguyen, P., Keller‐McGandy, C., Cantuti‐Castelvetri, I., Grammatopoulos, T. N., Standaert, D. G., Hyman, B. T., & McLean, P. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04310.x · Cited by 184
GDNF fails to exert neuroprotection in a rat -synuclein model of Parkinson's disease
Decressac, M., Ulusoy, A., Mattsson, B., Georgievska, B., Romero-Ramos, M., Kirik, D., & Bjorklund, A. (2011) · Brain · doi:10.1093/brain/awr149 · Cited by 178
Self-citationNeuroinflammation in Parkinson’s Disease
Lee, J.-K., Tran, T., & Tansey, M. G. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9176-0 · Cited by 171
Grommes, C., Lee, C. Y. D., Wilkinson, B. L., Jiang, Q., Koenigsknecht-Talboo, J. L., Varnum, B., & Landreth, G. E. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-007-9090-2 · Cited by 162
Zhang, W., Dallas, S., Zhang, D., Guo, J., Pang, H., Wilson, B., Miller, D. S., Chen, B., Zhang, W., McGeer, P. L., et al. (2007) · Glia · doi:10.1002/glia.20532 · Cited by 160
Park, J., Paik, S. R., Jou, I., & Park, S. M. (2008) · Glia · doi:10.1002/glia.20691 · Cited by 156
Hu, R., Xu, C., Shen, G., Jain, M. R., Khor, T. O., Gopalkrishnan, A., Lin, W., Reddy, B. S., Chan, J. Y., & Kong, A. T. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.06.019 · Cited by 151
α-Synuclein Expression Modulates Microglial Activation Phenotype
Austin, S. A., Floden, A. M., Murphy, E. J., & Combs, C. K. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1799-06.2006 · Cited by 150
Grealish, S., Mattsson, B., Draxler, P., & Björklund, A. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07265.x · Cited by 147
Kwak, M.-K., Cho, J.-M., Huang, B., Shin, S., & Kensler, T. W. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.05.029 · Cited by 146
Viral vector-mediated overexpression of α-synuclein as a progressive model of Parkinson’s disease
Ulusoy, A., Decressac, M., Kirik, D., & Björklund, A. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)84005-1 · Cited by 144
Self-citationKirik, D., Georgievska, B., Bürger, C., Winkler, C., Muzyczka, N., Mandel, R. J., & Björklund, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062047599 · Cited by 142
Self-citationInnamorato, N. G., Jaźwa, A., Rojo, A. I., García, C., Fernández‐Ruíz, J., Grochot‐Przeczek, A., Stachurska, A., Józkowicz, A., Dulak, J., & Cuadrado, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011838 · Cited by 141
Self-citationNuclear and neuritic distribution of serine-129 phosphorylated α-synuclein in transgenic mice
Schell, H., Hasegawa, T., Neumann, M., & Kahle, P. J. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.03.002 · Cited by 135
Proteasome Inhibition Induces Glutathione Synthesis and Protects Cells from Oxidative Stress
Yamamoto, N., Sawada, H., Izumi, Y., Kume, T., Katsuki, H., Shimohama, S., & Akaike, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603712200 · Cited by 135
Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease
von Otter, M., Landgren, S., Nilsson, S., Celojevic, D., Bergström, P., Håkansson, A. S., Nissbrandt, H., Droździk, M., Białecka, M. A., Kurzawski, M., et al. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-36 · Cited by 133
Kirik, D., Georgievska, B., Rosenblad, C., & Björklund, A. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01534.x · Cited by 133
Self-citationBianco, C. L., Déglon, N., Pralong, W. F., & Aebischer, P. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.06.008 · Cited by 132
Georgievska, B., Kirik, D., Rosenblad, C., Lundberg, C., & Björklund, A. (2002) · Neuroreport · doi:10.1097/00001756-200201210-00019 · Cited by 128
Self-citationVentral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression
Maingay, M., Romero‐Ramos, M., Carta, M., & Kirik, D. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.007 · Cited by 128
Self-citationBarone, M. C., Sykiotis, G. P., & Bohmann, D. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.007575 · Cited by 124
Modeling CNS neurodegeneration by overexpression of disease-causing proteins using viral vectors
Kirik, D., & Björklund, A. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00164-4 · Cited by 110
Self-citationChau, K., Ching, H. L., Schapira, A. H. V., & Cooper, J. A. D. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06191.x · Cited by 106
Role of microglial redox balance in modulation of neuroinflammation
Innamorato, N. G., Lastres‐Becker, I., & Cuadrado, A. (2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32832a3225 · Cited by 100
Self-citationvon Otter, M., Landgren, S., Nilsson, S., Zetterberg, M., Celojevic, D., Bergström, P., Minthon, L., Bogdanović, N., Andreasen, N., Gustafson, D., et al. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2009.12.007 · Cited by 96
Rat α‐Synuclein Interacts with Tat Binding Protein 1, a Component of the 26S Proteasomal Complex
Ghee, M., Fournier, A., & Mallet, J. J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752221.x · Cited by 96
Dopamine quinones interact with α-synuclein to form unstructured adducts
Bisaglia, M., Tosatto, L., Munari, F., Tessari, I., de Laureto, P. P., Mammi, S., & Bubacco, L. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.044 · Cited by 95
Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia
Lee, J., Zhu, W.-M., Stanić, D., Finkelstein, D. I., Horne, M. H., Henderson, J. M., Lawrence, A. J., O’Connor, L., Tomas, D., Drago, J., et al. (2008) · Brain · doi:10.1093/brain/awn085 · Cited by 95
Racchetti, G., D’Alessandro, R., & Meldolesi, J. (2011) · Glia · doi:10.1002/glia.22280 · Cited by 78
Glial involvement in diffuse Lewy body disease
Terada, S., Ishizu, H., Yokota, O., Tsuchiya, K., Nakashima, H., Ishihara, T., Fujita, D., Uéda, K., Ikeda, K., & Kuroda, S. (2003) · Acta Neuropathologica · doi:10.1007/s00401-002-0622-9 · Cited by 73
Bukhatwa, S., Zeng, B., Rose, S., & Jenner, P. G. (2010) · Brain Research · doi:10.1016/j.brainres.2010.02.045 · Cited by 70
Dopamine-Induced Conformational Changes in Alpha-Synuclein
Outeiro, T. F., Klucken, J., Bercury, K. K., Tetzlaff, J. E., Putcha, P., Oliveira, L. M. A., Quintas, A., McLean, P. J., & Hyman, B. T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006906 · Cited by 66
Marx, F. P., Soehn, A. S., Berg, D., Melle, C., Schiesling, C., Lang, M., Kautzmann, S., Strauss, K. M., Franck, T., Engelender, S., et al. (2007) · The FASEB Journal · doi:10.1096/fj.06-6734com · Cited by 52
TAM Receptor Signalling and Demyelination
Binder, M. D., & Kilpatrick, T. J. (2009) · Neurosignals · doi:10.1159/000231894 · Cited by 51
McNaught, K. S. P., JnoBaptiste, R., Jackson, T., & Jengelley, T. (2009) · Synapse · doi:10.1002/syn.20719 · Cited by 37
Assessment of GDNF in Primate Models of Parkinson's Disease: Comparison with Human Studies
Eslamboli, A. (2005) · Reviews in the Neurosciences · doi:10.1515/revneuro.2005.16.4.303 · Cited by 29
Design-Based Stereology in Brain Aging Research
Schmitz, C., & Hof, P. R. (2007) · CRC Press eBooks · doi:10.1201/9781420005523-4 · Cited by 21
Increase of GAP‐43 in the rat cerebellum following unilateral striatal 6‐OHDA lesion
Perović, M., Mladenović, A., Rakić, L., et al. (2005) · Synapse · doi:10.1002/syn.20142 · Cited by 15
Nuclear localization of the 20S proteasome subunit in Parkinson's disease
Nakamura, A., Kitami, T., Mori, H., Mizuno, Y., & Hattori, N. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.07.050 · Cited by 14
Design-Based Stereology in Brain Aging Research
Schmitz, C., & Hof, P. R. (2007) · Frontiers in neuroscience · doi:10.1201/9781420005523.sec2 · Cited by 8
Research works printed but not linked: 1
- Suganuma, 2011, Stimulation of phagocytosis by sulforaphane, Biochem. Biophys. Res. Commun., 405, 146, 10.1016/j.bbrc.2011.01.025 · doi:10.1016/j.bbrc.2011.01.025
Cited by
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
Cuadrado, A., Rojo, A. I., Wells, G., Hayes, J. D., Cousin, S. P., Rumsey, W. L., Attucks, O. C., Franklin, S., Levonen, A.-L., Kensler, T. W., et al. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0008-x · Cited by 1,438
Self-citationα-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies
Wong, Y. C., & Krainc, D. (2017) · Nature Medicine · doi:10.1038/nm.4269 · Cited by 897
Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications
Pajares, M., I. Rojo, A., Manda, G., Boscá, L., & Cuadrado, A. (2020) · Cells · doi:10.3390/cells9071687 · Cited by 779
Self-citationBuendia, I., Michalska, P., Navarro, E., Gameiro, I., Egea, J., & León, R. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.11.003 · Cited by 678
Sivandzade, F., Prasad, S., Bhalerao, A., & Cucullo, L. (2019) · Redox Biology · doi:10.1016/j.redox.2018.11.017 · Cited by 639
Metadata
- Authors
- Lastres-Becker, I., Ulusoy, A., Innamorato, N. G., Sahin, G., Rábano, A., Kirik, D., & Cuadrado, A.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-04-18
- Volume
- 21
- Issue
- 14
- Pages
- 3173-3192
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2151725579
- Cited by
- 263
- References
- 70
- FWCI
- 8.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.